We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
751
STAAR Surgical
STAA
$1.14B
$665K 0.04%
62,565
+35,950
+135% +$427K
JJSF icon
752
J&J Snack Foods
JJSF
$1.59B
$662K 0.03%
7,073
-900
-11% -$84.8K
SNEX icon
753
StoneX
SNEX
$9.2B
$661K 0.03%
+193,251
New +$728K
MSL
754
DELISTED
Midsouth Bancorp, Inc.
MSL
$661K 0.03%
+35,327
New +$679K
ALK icon
755
Alaska Air
ALK
$5.81B
$660K 0.03%
15,161
-22,889
-60% -$1.06M
AJG icon
756
Arthur J. Gallagher & Co
AJG
$64.3B
$659K 0.03%
14,530
-627
-4% -$28.8K
DHR icon
757
Danaher
DHR
$140B
$658K 0.03%
12,877
-20,126
-61% -$1.03M
OFG icon
758
OFG Bancorp
OFG
$2.25B
$658K 0.03%
43,924
+1,024
+2% +$16.7K
MACK
759
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$657K 0.03%
9,514
+3,241
+52% +$173K
DCP
760
DELISTED
DCP Midstream, LP
DCP
$654K 0.03%
12,011
-1,845
-13% -$101K
ARW icon
761
Arrow Electronics
ARW
$11.6B
$653K 0.03%
11,797
-10,707
-48% -$646K
JNS
762
DELISTED
Janus Capital Group Inc
JNS
$652K 0.03%
+44,819
New +$544K
JBL icon
763
Jabil
JBL
$35.5B
$650K 0.03%
32,220
+3,600
+13% +$75.2K
CDP icon
764
COPT Defense Properties
CDP
$4.24B
$648K 0.03%
25,188
-7,729
-23% -$216K
WHG icon
765
Westwood Holdings Group
WHG
$182M
$648K 0.03%
11,435
+1,900
+20% +$110K
PRSU
766
Pursuit Attractions and Hospitality Inc
PRSU
$1.38B
$644K 0.03%
31,200
+10,035
+47% +$222K
CHE icon
767
Chemed
CHE
$7.14B
$643K 0.03%
+6,247
New +$633K
CSIQ icon
768
Canadian Solar
CSIQ
$1.05B
$643K 0.03%
17,971
+1,984
+12% +$64.3K
NRT
769
North European Oil Royalty Trust
NRT
$79.8M
$643K 0.03%
31,030
+8,301
+37% +$186K
NWY
770
DELISTED
New York & Co Inc
NWY
$643K 0.03%
212,243
-7,245
-3% -$24.4K
EA icon
771
Electronic Arts
EA
$52.9B
$642K 0.03%
18,015
-39,392
-69% -$1.44M
ATML
772
DELISTED
ATMEL CORP
ATML
$640K 0.03%
+79,175
New +$685K
CLX icon
773
Clorox
CLX
$12.8B
$639K 0.03%
6,655
-7,084
-52% -$641K
RBBN icon
774
Ribbon Communications
RBBN
$384M
$638K 0.03%
37,292
+32,144
+624% +$613K
GTE icon
775
Gran Tierra Energy
GTE
$334M
$637K 0.03%
11,499
-1,863
-14% -$124K

Similar funds

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.